FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson ' s Disease

SAN DIEGO, Oct. 19, 2023 /PRNewswire/ -- Aspen Neuroscience today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ANPD001 for the treatment of Parkinson ' s disease (PD) to improve motor function....
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials